Board Meeting Details
The Board of Directors meeting was held on May 27, 2026, from 5:45 PM to 7:15 PM.
Key Board Decisions
- Approved and took on record Audited Standalone and Consolidated Financial Results for quarter and year ended March 31, 2026
- Decided to pass over dividend for the year 2025-26
- Approved holding Annual General Meeting on Tuesday, August 25, 2026 at 11:00 AM at Registered Office
- Share Transfer Books and Register of Members to be closed from Wednesday, August 19, 2026 to Tuesday, August 25, 2026 (both days inclusive)
- Re-appointed RRK & Co, Chartered Accountants as Internal Auditors for Financial Year 2026-27
- Re-appointed Mr. Cedric Lobo (DIN: 09124746) as Whole Time Director designated as "Executive Director" for 2 years from June 01, 2026 to May 31, 2028, subject to shareholder approval
- Re-appointed Mr. K.G. Gupta (DIN: 00051863) as Chairman and Managing Director for 3 years from April 01, 2027 to March 31, 2030, subject to shareholder approval
Financial Results - Standalone (₹ in Lakhs)
Quarter Ended March 31, 2026:
- Revenue from operations: 640.18
- Other income: 99.00
- Total income: 739.18
- Total expenses: 782.35
- Loss before exceptional items and tax: (43.17)
- Exceptional items: 149.40
- Loss before tax: (192.57)
- Tax expense: (4.26) [Deferred tax]
- Loss for the period: (188.31)
- Other comprehensive income: 12.12
- Total comprehensive loss: (176.19)
- Basic EPS: (₹3.74)
- Diluted EPS: (₹3.74)
Year Ended March 31, 2026:
- Revenue from operations: 2,564.41
- Other income: 596.81
- Total income: 3,161.22
- Total expenses: 3,346.72
- Loss before exceptional items and tax: (185.50)
- Exceptional items: 178.99
- Loss before tax: (364.49)
- Tax expense: (7.70) [Deferred tax]
- Loss for the year: (356.79)
- Other comprehensive income: 21.91
- Total comprehensive loss: (334.88)
- Basic EPS: (₹7.08)
- Diluted EPS: (₹7.08)
- Paid-up equity share capital: 504.06 (face value ₹10 each)
- Reserves: 928.48
Financial Results - Consolidated (₹ in Lakhs)
Quarter Ended March 31, 2026:
- Revenue from operations: 2,979.27
- Other income: 80.66
- Total income: 3,059.93
- Total expenses: 2,799.99
- Profit before share of profit/loss of associate and exceptional items: 259.94
- Share in loss of associate: (2.86)
- Profit before exceptional items: 257.08
- Exceptional items: 149.40
- Profit before tax: 107.68
- Tax expense: (4.26) [Deferred tax]
- Profit for the period: 111.94
- Other comprehensive loss: (213.18)
- Total comprehensive loss: (101.24)
- Basic EPS: ₹0.38
- Diluted EPS: ₹0.38
Year Ended March 31, 2026:
- Revenue from operations: 14,906.35
- Other income: 224.48
- Total income: 15,130.83
- Total expenses: 14,635.59
- Profit before share of profit/loss of associate and exceptional items: 495.24
- Share in loss of associate: (5.88)
- Profit before exceptional items: 489.36
- Exceptional items: 178.99
- Profit before tax: 310.37
- Tax expense: 7.66
- Profit for the year: 302.71
- Other comprehensive loss: (405.97)
- Total comprehensive loss: (103.26)
- Basic EPS: ₹2.42
- Diluted EPS: ₹2.42
- Paid-up equity share capital: 504.06
- Reserves: 4,779.25
Exceptional Items
Exceptional items of ₹178.99 lakhs for the year ended March 31, 2026, comprise additional provisions for employee benefits due to implementation of new labor codes:
- ₹29.59 lakhs recognized in Q3 FY26 for gratuity liability
- Additional ₹120.69 lakhs for gratuity and ₹28.71 lakhs for compensated absences recognized in Q4 FY26
Subsidiary Update
GSV Ophthalmics Private Limited, a material subsidiary, underwent voluntary winding up effective November 21, 2025. Total investment of ₹11.70 crore has been realized, with additional ₹69.72 lakhs received as residual share of equity (deemed dividend).
Audit Details
- Statutory Auditor: M S K A & Associates LLP (ICAI Firm Registration No. 105047W/W101187)
- Audit Report issued with unmodified opinion on both standalone and consolidated financial results
- Declaration from CFO provided regarding audit report with unmodified opinion